Prediction of Relapse and Steroid Dependency in Pediatric Ulcerative Colitis

Mehmet Onder1, Cigdem Omur Ecevit1, Safak Pelek1

  • 1Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Health Sciences Dr. Behcet Uz Children's Hospital, Izmir 35210, Türkiye.

PubMed

Insights

This study identifies key predictors for steroid dependence and relapse in pediatric ulcerative colitis, suggesting a need for a scoring system to guide treatment decisions and optimize the use of advanced therapies.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Clinical Medicine

Background:

  • Ulcerative colitis (UC) management in children requires identifying patients at risk for steroid dependence and relapse.
  • Early identification allows for timely escalation to second-line therapies, improving outcomes.

Purpose of the Study:

  • To determine predictive criteria for steroid dependence and relapse in pediatric ulcerative colitis (UC).
  • To provide data supporting earlier transitions to second-line treatments when necessary.

Main Methods:

  • Retrospective analysis of 62 pediatric UC patients (2018-2023).
  • Inclusion of demographic data, complete blood count, inflammatory markers, immunoglobulin levels, and nutritional status.
  • Utilized univariate regression and receiver operating characteristic (ROC) curve analysis.

Main Results:

  • Inverse correlation found between IgM levels and relapse/steroid dependence (p<0.01, p=0.03).
  • Steroid dependence associated with hemoglobin, hematocrit, WBC, neutrophil, platelet counts, and albumin levels (p<0.01-0.03).
  • MMES significantly predicted steroid dependence in pancolitis (AUC: 0.75, p=0.01).

Conclusions:

  • A scoring system is needed for pediatric UC, similar to Crohn's disease, to guide anti-TNF therapy use.
  • Initial disease severity is a critical factor for steroid dependence.
  • A comprehensive scoring system including lab values, disease extent, and severity indices is recommended.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
499
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
962
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.7K